Indeed, our studies revealed that several AR downstream targets, such as FSHR, ANGPT1, and LHCGR genes, which were previously reported to be significantly elevated in patients with PCOS [60–62], were increased in hyperandrogenic ovaries and MPGCs (Fig. 1G, I). This evidence concerns the gene FSHR and polycystic ovary syndrome.